Akèy › Tit travay › Scientist I
Scientist I: Salè H-1B
701 aplikasyon kondisyon travay te itilize tit travay Scientist I. Salè baz medyàn ofri $77,250; mwatye mitan $66,685–$97,000.
Demann (LCA)701
Salè medyan ofri$77,250
Mwatye salè yo$66,685–$97,000
10yèm–90yèm pousantaj$60,000–$119,025
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| University of Wisconsin System | 215 | $67,824 |
| The University of Alabama at Birmingham | 49 | $70,000 |
| Allen Institute | 36 | $82,742 |
| Tessera Therapeutics, Inc. | 27 | $115,000 |
| University of Kentucky | 26 | $55,141 |
| Leidos Biomedical Research, Inc. | 17 | $96,907 |
| Univ of WI System | 13 | $68,340 |
| The Henry M. Jackson Foundation | 12 | $73,800 |
| Dana-Farber Cancer Institute | 9 | $89,685 |
| CZ Biohub SF, LLC | 8 | $112,549 |
| BioAgilytix Labs, LLC | 7 | $90,000 |
| AbbVie Bioresearch Center Inc. | 7 | $100,000 |
| KBI Biopharma, Inc. | 7 | $90,000 |
| Riconpharma, LLC | 7 | $70,000 |
| Resolian f.k.a. Alliance Pharma, Inc. | 7 | $93,636 |
| Frontage Laboratories, Inc. | 7 | $65,333 |
| Southern Research Institute | 6 | $65,788 |
| McNeal Professional Services, Inc. | 6 | $63,440 |
| Entrada Therapeutics, Inc. | 6 | $112,301 |
| International Flavors & Fragrances, Inc. | 6 | $91,400 |
| HD Biosciences, Inc. | 5 | $75,000 |
| University of Wisconsin-Milwaukee | 5 | $60,935 |
| Generate Biomedicines, Inc. | 5 | $115,000 |
| AbbVie Inc. | 4 | $92,386 |
| Takeda Development Center Americas, Inc. | 4 | $126,424 |
| Metagenomi, Inc. | 4 | $122,500 |
| Kenox Pharmaceuticals, Inc. | 4 | $92,500 |
| PPD Development, L.P. | 4 | $49,494 |
| Eurofins Professional Scientific Services Midwest, LLC. | 4 | $44,346 |
| UCB BioSciences Inc. | 3 | $86,549 |
| Mammoth Biosciences Inc. | 3 | $128,154 |
| Seqirus Inc. | 3 | $113,850 |
| Cayman Chemical Company Incorporated | 3 | $80,000 |
| Cytokinetics, Inc. | 3 | $130,437 |
| Sanofi US Services Inc. | 3 | $98,121 |
| Emulate, Inc. | 3 | $71,050 |
| Arena BioWorks LLC | 3 | $105,000 |
| XenoBiotic Laboratories, Inc., a div. of WuXi | 3 | $80,000 |
| Ayana Bio LLC | 3 | $133,900 |
| Sanford Burnham Prebys Medical Discovery Institute | 3 | $88,000 |
| Granules Pharmaceuticals Inc. | 2 | $98,136 |
| Abzena (Bristol) LLC | 2 | $83,651 |
| PetDx, Inc. | 2 | $80,000 |
| Integris BioServices, LLC | 2 | $76,500 |
| Appia Bio, Inc. | 2 | $94,040 |
| Lyterian Therapeutics | 2 | $131,650 |
| Ameditech Inc. | 2 | $96,000 |
| University Corporation for Atmospheric Research | 2 | $88,840 |
| Primera Analytical Solutions Corporation | 2 | $76,400 |
| Bayer U.S. LLC | 2 | $130,000 |
| IGM Biosciences, Inc | 2 | $126,500 |
| The Roskamp Institute, Inc. | 2 | $50,000 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 2 | $56,056 |
| Alltrna, Inc. | 2 | $112,500 |
| Dicerna Pharmaceuticals, Inc. | 2 | $124,488 |
| Illumina, Inc. | 2 | $87,500 |
| Wave Life Sciences USA, Inc. | 2 | $118,000 |
| Forge Biologics | 2 | $92,700 |
| WuXi Biologics USA, LLC | 2 | $81,789 |
| Scribe Therapeutics Inc. | 2 | $125,978 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $68,000 |
| Nivo II (kalifye) | $89,773 |
| Nivo III (eksperyans) | $105,706 |
| Nivo IV (plen kompetans) | $109,302 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 147 | $77,500 |
| FY2024 | 185 | $80,253 |
| FY2025 | 207 | $77,250 |
| FY2026 | 142 | $74,628 |
Vil yo
- Madison, WI217
- Birmingham, AL54
- Seattle, WA37
- Cambridge, MA35
- Somerville, MA31
- Boston, MA29
- Lexington, KY24
- San Diego, CA20
- South San Francisco, CA18
- Frederick, MD16
- San Francisco, CA11
- Lexington, MA10
- Silver Spring, MD10
- Durham, NC9
- Bethesda, MD9
- Malvern, PA8
- Denville, NJ7
- Emeryville, CA6
- Cranbury, NJ6
- Exton, PA6
- Worcester, MA5
- La Jolla, CA5
- Milwaukee, WI5
- Middleton, WI5
- Ann Arbor, MI4
- San Carlos, CA4
- Monmouth Junction, NJ4
- Kalamazoo, MI4
- Brisbane, CA3
- Waltham, MA3
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).